Finance

Lists
049960:KOSDAQ
Cell Biotech Co Ltd
₩15,240.00
+0.93%
(+140.00) 1D
Oct 19, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 049960...
Open
₩15,230
High
₩15,280
Low
₩14,900
Mkt. cap
143.26B
Avg. vol.
7.05K
Volume
6.42K
Dividend
3.94%
Quarterly dividend
₩150
Ex-dividend date
Dec 27, 2023
P/E ratio
6.21
52-wk high
₩18,500
52-wk low
₩11,350
EPS
₩2,455
Shares outstanding
9.40M
No. of employees
100
Open
₩15,230
High
₩15,280
Low
₩14,900
Mkt. cap
143.26B
Avg. vol.
7.05K
Volume
6.42K
Dividend
3.94%
Quarterly dividend
₩150
Ex-dividend date
Dec 27, 2023
P/E ratio
6.21
52-wk high
₩18,500
52-wk low
₩11,350
EPS
₩2,455
Shares outstanding
9.40M
No. of employees
100
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
30 minutes ago
Magnificent Seven Are Losing Their Earnings Luster
About Cell Biotech Co Ltd
CEOMyung-jun Chung
Employees100
Founded1995
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.36B
14.63B
14.60B
15.81B
Cost of goods sold
4.42B
3.98B
3.99B
4.32B
Cost of revenue
4.42B
3.98B
3.99B
4.32B
Research and development expenses
846.82M
941.81M
988.72M
1.17B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.22B
6.03B
5.78B
7.97B
Operating expense
8.72B
7.60B
7.42B
9.85B
Total operating expenses
13.14B
11.58B
11.41B
14.17B
Operating income
2.22B
3.05B
3.19B
1.64B
Other non operating income
46.11M
61.38M
43.33M
50.68M
EBT including unusual items
4.10B
4.68B
6.62B
4.23B
EBT excluding unusual items
4.17B
4.52B
6.62B
3.62B
Income tax expense
648.29M
290.10M
1.27B
620.31M
Effective tax rate
15.82%
6.19%
19.19%
14.68%
Other operating expenses
49.84M
40.45M
41.09M
96.57M
Net income
3.45B
4.39B
5.35B
3.61B
Net profit margin
22.46%
30.02%
36.66%
22.80%
Earnings per share
-
-
-
-
Interest and investment income
689.61M
691.29M
658.74M
670.76M
Interest expense
-7.37M
-5.68M
-4.23M
-2.60M
Net interest expenses
682.24M
685.61M
654.51M
668.16M
Depreciation and amortization charges
537.83M
544.32M
557.83M
564.44M
EBITDA
3.11B
3.95B
4.09B
2.54B
Gain or loss from assets sale
2.00K
170.99M
-
-609.96M
AI content may include mistakes. Learn more
Google apps